Page 1 | Search Results | Journal of Experimental Medicine | Rockefeller University Press

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies

Shravan Madireddi, So-Young Eun, Seung-Woo Lee, Ivana Nemčovičová, Amit Kumar Mehta, Dirk M. Zajonc, Nozomu Nishi, Toshiro Niki, Mitsuomi Hirashima, Michael Croft

J Exp Med (2014) 211 (7): 1433–1448.

https://doi.org/10.1084/jem.20132687

Published: 23 June 2014

View articletitled, Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies

Includes: Supplementary data

Journal Articles

The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode

Yali Li, Enrico Girardi, Jing Wang, Esther Dawen Yu, Gavin F. Painter, Mitchell Kronenberg, Dirk M. Zajonc

J Exp Med (2010) 207 (11): 2383–2393.

https://doi.org/10.1084/jem.20101335

Published: 04 October 2010

View articletitled, The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode

Includes: Supplementary data

Journal Articles

Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity

Dirk M. Zajonc, Igor Maricic, Douglass Wu, Ramesh Halder, Keshab Roy, Chi-Huey Wong, Vipin Kumar, Ian A. Wilson

J Exp Med (2005) 202 (11): 1517–1526.

https://doi.org/10.1084/jem.20051625

Published: 28 November 2005

View articletitled, Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity